Reinforcing its ongoing commitment to leadership in the global medical technology market, Boston Scientific Corporation (NYSE: BSX) today officially opened the China branch of the Boston Scientific Institute for Advancing Science (IAS) as well as its new Innovation Center in the country.
DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction, announced the launch of new instrumentation that enables less invasive surgical fixation and stabilization of rib fractures with the company's MatrixRIB™ System of precontoured, low-profile titanium plates, locking screws and intramedullary splints.
Smith & Nephew wants a federal judge in California to toss a lawsuit filed by a doctor who blames a botched hip implantation on the British medical device company. Dr. David Chao sued Smith & Nephew in the U.S. District Court for Southern California, alleging that inadequate training and faulty surgical scissors for SNN's Birmingham Hip Resurfacing implant led to the botched surgery on Kathleen Adams in 2007.
Smith & Nephew, the global medical technology business, announces the US introduction of DURAFIBER Ag antimicrobial gelling fiber dressing. This new offering in the DURAFIBER portfolio combines the highly absorbent, gelling fiber filler dressing with the benefits of silver (Ag).
Doctor visits tend to be quiet affairs, unless an MRI exam, or a root canal, is on the agenda. An MR scanner can generate noise in excess of 110 decibels, enough to rival a rock concert. There is a good reason why this happens. “An MRI scanner is like a huge version of a speaker in your home,” says engineer Bryan Mock, who manages GE Healthcare’s MRI products.
A federal appeals court overturned a portion of a legal win for St. Jude Medical yesterday, ruling that a lower court erred in invoking the "safe harbor" provision against double-patenting claims in a patent infringement lawsuit against Access Closure Inc.
A federal appeals court upheld a lower court's decision to toss a lawsuit filed in 2010 accusing Medtronic of violating patents held by W.L. Gore & Associates covering stent graft manufacturing techniques. Judge Mark Davis of the U.S. District Court for Eastern Virginia dismissed Gore's claims last year, saying the ruling made Medtronic's counterclaims moot.
El Camino Hospital Enrolls Second Patient in Global Clinical Trial Evaluating the Medtronic CoreValve® System in Intermediate Risk Patients with Aortic Valve DiseaseSeptember 11, 2013 3:38 pm | by Business Wire | News | Comments
El Camino Hospital, in partnership with the Taft Center for Clinical Research and the Fogarty Clinical Research Institute, both a part of the Fogarty Institute for Innovation, announced today that it has enrolled its second patient in a global clinical trial comparing the Medtronic CoreValve® System with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk for open-heart surgery.
Consumers Union is pushing device makers to equip patients with warranties so they will have a better understanding of how long an implant is expected to last and a clear process to follow in the event that it fails prematurely. Ultimately, warranties will encourage companies to make their devices safer and more durable, according to Consumers Union.
The family of a lung cancer patient who suffered injuries after he was exposed to overdoses of radiation has settled a lawsuit for $15 million in compensation. Zacarias Chichioco Jr. received about 2.5 times the appropriate amount of radiation he should have received because of a programming error in software developed and sold by a medical services company, according to the lawsuit.
Boston Scientific keeps hitting high notes on Wall Street, most recently setting a new 4-year record in the days following the publication of a new study touting the company's Alair bronchial thermoplasty system. The medical device giant announced this week that the Alair system proved safe and effective in reducing severe asthma attacks over at least 5 years...
Medtronic is working with New England hospitals and government health officials to track the movement of surgical medical equipment involved in several cases of possible patient exposure to Creutzfeldt-Jakob disease, a rare and fatal relative to the more commonly known "mad cow" disease.
FDA regulators put their highest-risk Class I label on Siemens' (NYSE:SI) recall of more than 78,000 of its MicroScan Synergies plus and MicroScan rapID/S plus antimicrobial tests, warning that false test results could hinder patient care.
Abbott announced today promising preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack.
Medtech titan Medtronic opened the doors on a new Center of Excellence in Singapore, where new business models will be designed, tested and scaled for Asian markets. Based in Medtronic's existing Singapore facility, the new center will also develop commercial models that may eventually extend to various markets around the globe after passing muster in a single country.
Technology giant Philips awarded a 10-year contract for continuous access of its ultrasound devices to the cardiology department at Medical Center Leeuwarden, a teaching hospital in the Netherlands. The Dutch hospital will also receive training services and periodic structural upgrades as part of the deal.
Both C.R. Bard and Rochester Medical got some stock market love today after the companies signed a definitive merger agreement, but Rochester was the clear Wall Street darling with a more than 40% bump in shares by early afternoon trading.
Terumo to Showcase BSD's MicroThermX® Microwave Ablation System at CIRSE – World's Largest Interventional Radiology ConferenceSeptember 4, 2013 9:15 am | by Business Wire | News | Comments
BSD Medical Corporation announced today that Terumo Europe NV, a wholly owned subsidiary of Terumo Corporation, will showcase BSD's MicroThermX ® Microwave Ablation System (MicroThermX) at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) conference.
New data on Medtronic's Symplicity renal denervation system showed the device is safe and effective at 1 and 3 years, the company announced this week. A pair of analyses released during the the European Society of Cardiology Congress in Amsterdam this week showed positive results for the hypertension treatment system.
Biomet amended its Q4 and annual earnings report to reflect a swing to red in Q4 and much deeper losses for the full year compared to earlier reports. The Warsaw, Ind.-based orthopedics company posted losses of $221.2 million on $784 million in sales during the 3-month period ended May 31, 2013.
Medtronic Announces Formation of Hospital Solutions Business Aimed at Driving Efficiencies and Cost SavingsSeptember 2, 2013 12:06 pm | by The Associated Press | News | Comments
Medtronic, Inc. (NYSE: MDT) today announced the formation of Medtronic Hospital Solutions, a new business focused on developing novel partnerships with hospitals to provide services directly related to hospital operational efficiency. The new business will focus initially on offering services in Europe...
The U.S. Food and Drug Administration (FDA) hit Allendale, NJ-based Stryker’s Spine division with a Class I recall for the company’s OASYS Midline Occiput Plate. According to reports, Stryker learned that a post-operative fracture can occur in the pin that connects ...
St. Jude Medical, Inc., a global medical device company, today announced the CE Mark approval of its next-generation EnligHTN Renal Denervation System for treating patients with drug-resistant, uncontrolled hypertension. The system features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter...
When Medtronic announced that it paid $200 million in cash for chronic disease management firm Cardiocom the medical device giant said the acquisition was indicative of a broader vision for the company's future, but Wall Street analysts are warning that it may also suggest "challenging times ahead" for the device industry.
Biomet will go to bat over its M2A-magnum metal-on-metal hip implants after failing to convince an Indiana federal judge that a personal injury lawsuit was preempted by FDA rules. The plaintiff, Leslie Caccia, sued Biomet for a supposedly defective metal-on-metal hip implant in what is now part of a larger multi-district litigation.